← Back
Data updated: Mar 10, 2026
SWISS PHARM
Cardiovascular
SWISS PHARM is a generic drug manufacturer focused on Cardiovascular.
2020
Since
3
Drugs
-
Trials
24
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
VENLAFAXINE HYDROCHLORIDE 2026-01-30
Labeling
VENLAFAXINE HYDROCHLORIDE 2025-09-17
Labeling
VENLAFAXINE HYDROCHLORIDE 2025-09-02
Labeling
VENLAFAXINE HYDROCHLORIDE 2025-09-02
Labeling
VENLAFAXINE HYDROCHLORIDE 2025-04-23
Labeling
VENLAFAXINE HYDROCHLORIDE 2025-04-23
Labeling
VENLAFAXINE HYDROCHLORIDE 2025-04-23
Labeling
VENLAFAXINE HYDROCHLORIDE 2025-04-23
Labeling
VENLAFAXINE HYDROCHLORIDE 2025-02-07
VENLAFAXINE HYDROCHLORIDE 2025-01-28
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 100%
1 drugs
Pipeline Strength Pro
Loading...
Active (2)
Discontinued (1)
Company Info
- First Approval
- 2020-08-10
- Latest
- 2022-11-18
- Applications
- 3